Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004357 · ClinicalTrials.gov registry record · Phase 2
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00004357 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 6 participants.
The verdict
NCT00004357, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Juvenile dermatomyositis (JDM) is a connective tissue disease that causes skin rash and weak muscles in children. The purpose of this study is to measure the absorption of oral prednisolone and intravenous (IV) methylprednisolone and to determine levels of disease activity indicators in the blood. These levels will be compared to see if there are patterns specific to active and less active JDM.
Interventions
- DRUG Methylprednisolone
- DRUG Prednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1997-09 |
| Est. Completion | 2008-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004357
The ClinicalTrials.gov registry entry for NCT00004357 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone is the first listed.
NCT00004357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004357 about?
NCT00004357 is a clinical study titled "Absorption of Corticosteroids in Children With Juvenile Dermatomyositis". Juvenile dermatomyositis (JDM) is a connective tissue disease that causes skin rash and weak muscles in children. The purpose of this study is to measure the absorption of oral prednisolone and intravenous (IV) methylprednisolone and to determine levels of disease activity indicators in the blood. T...
What is the current status of trial NCT00004357?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 1997-09. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00004357?
The interventions under investigation include: Methylprednisolone (DRUG), Prednisolone (DRUG).
Who is sponsoring clinical trial NCT00004357?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.